← Evidence map

ArticleFrontiers in oncology2026

Past, present and future of nivolumab: new horizons in immuno-oncology.

Inamul Hasan Madar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42022314